Discovery of fifth serotype of dengue virus (denv-5): A new public health dilemma in dengue control

Medical Journal Armed Forces India

Volumn 71, Issue 1, 2015, Pages 67-70

  Mustafa, M S ^a   Rasotgi, V ^b   Jain, S ^c   Gupta, V ^d  

^a Station Health Organisation (Large)   (India)

^b AFMS (Pensions) O o DGAFMS   (India)

^c HQ 11 Corps ^*  (India)

^d 136 Station Health Organisation ^*  (India)

Author keywords

Dengue fever; Dengue vaccine; Serotype; Sylvatic

Indexed keywords

DENGUE VACCINE;

ARTICLE; BOTTLENECK POPULATION; COST EFFECTIVENESS ANALYSIS; DENGUE; DENGUE VIRUS; DENGUE VIRUS 5; DISEASE SURVEILLANCE; GENETIC RECOMBINATION; HUMAN; INDIA; INFECTION CONTROL; INFECTION PREVENTION; MICROBIAL DIVERSITY; NATURAL SELECTION; NONHUMAN; PHYLOGENY; PUBLIC HEALTH PROBLEM; SEROTYPE; SYLVATIC DENGUE STRAIN; VECTOR CONTROL; VIRUS ISOLATION; VIRUS MUTATION; VIRUS STRAIN;

EID: 84921269643     PISSN: 03771237     EISSN: 22134743     Source Type: Journal    
DOI: 10.1016/j.mjafi.2014.09.011     Document Type: Review

References (12)

1. Mustafa MS, Bansal AS, Rastogi V. Flightless Aedes mosquitoes in dengue control. MJAFI. 2011;67:192-193
2. Holmes EC. Molecular epidemiology and evolution of emerging infectious diseases. Brit Mel Bull. 1998;54:533-543
3. Normile D. Surprising new dengue virus throws a spanner in disease control efforts. Science. 2013;342:415
4. Calisher CH. Antigenic relationships between flaviviruses as determined by crossneutralization tests with polyclonal antisera. J Gen Virol. 1989;70:37-43
5. Monath TP. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci USA. 1994;91:2395-2400
6. Vasilakis N, Cardosa J, Hanley KA, Holmes EC, Weaver SC. Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat Rev Microbiol. 2012;9:532-541
7. Rudel TK, Defries R, Asner GP, Laurance WF. Changing drivers of deforestation and new opportunities for conservation. Conserv Biol. 2009;23:1396-1405
8. May RM, Gupta S, McLean AR. Infectious disease dynamics: what characterizes a successful invader? Phil Trans R Soc Lond. 2001;356:901-910
9. Mustafa MS, Agrawal VK. Dengue vaccine: the current status. MJAFI. 2008;64:161-164
10. Sabchareon A, Wallace D, Sirivichayakul C, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai school children: a randomised, controlled phase 2b trial. Lancet. 2012;380:1559-1567
11. Mutero CM, Schlodder D, Kabatereine N, Kramer R. Integrated vector management for malaria control in Uganda: knowledge, perceptions and policy development. Malar J. 2012;11:21
12. Sanchez L, Maringwa J, Shkedy Z, et al. Testing the effectiveness of community-based dengue vector control interventions using semiparametric mixed models. Vector Borne Zoonotic Dis. 2012;12:609-615.